Arkolith/Insider Trading/CTNM/Form 4

Lorrain Daniel S.

Chief Scientific OfficerContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$595K
Net Open-Market Flow
-$595K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)6K$15.67$92K138K
Jul 1, 2026Option exercise(M)4K$1.01$4K144K
Jul 1, 2026Sell(S)3K$16.24$41K135K
Jun 30, 2026Option exercise(M)29K$1.01$29K168K
Jun 30, 2026Sell(S)29K$16.04$462K139K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)4K—$034K
Jun 30, 2026Option exercise(M)29K—$038K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-047058) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML